Report Store

Competitive Intelligence/News Letter Epidemiology Reports Market Analysis Reports Market Snapshots Reports Pipeline Landscape Reports Regulatory Analysis Reports
Animal Health Consumer & OTC Products Healthcare IT Medical Devices Pharma & Biotech
Bone & Joint disorders Cardiovascular Disorder Dermatological Disorder Ear Nose Throat Disorders Endocrinological Disorder Gastrointestinal Disorders Genetic Disorders Genito Urinary System And Sex Hormones Gynaecological Disorder Hematological Disorders Hepatological Disorder Hormonal Disorders Immunological Disorder Immunotherapy Infectious Disease Male Health Metabolic Disorders Mouth and Dental Disorders Musculoskeletal Disorders Nephrological Disorder Neurological Disorder Nutrition and weight loss Nutritional Disorders Oncology Ophthalmological Disorder Others Reproductive Health Respiratory disorders Toxicology Urology Vaccines Womens Health
Imaging Implantable In vitro diagnostics Medical device accessories Medical equipment Mobility aid services Non-invasive monitoring Others Personal protective equipment Single use devices Software as Medical Devices Surgical and laboratory instruments

Applied Filter(s) Clear Filter

Type:

Industry:

Therapy Area:

Category: Imaging

Nuclear Medicine Therapeutics Market

Report ID: PNMD1165 Industry: Medical Devices Category: Imaging

A pharmaceutical composition including radioactive elements is known as therapeutic nuclear medicine.The nuclear medicine therapeutics market was valued at USD 1 billion in 2021 and is expected to reach USD 1.8 billion by 2027, exhibiting a CAGR of 9.6% during the forecast period 2022-2027. The growth could be attributed to the return of demand to pre-pandemic levels, increasing authorization of novel & innovative medicines, extensive research, disease prevalence, and immunotherapies. 

Buy Now Request Sample

Price from : $3000

Why Choose Us

Inclusion of Pre-clinical Molecules

Other than an extensive coverage of clinical and commercial drugs, our reports also provide details about pre-clinical molecules!

Start-up
Profiling

One of our marquee services We profile relevant start-up companies in the market.

KOL
Insight's

Get access to reliable data our insights and analyses are backed by Key Opinion Leaders in the field.

Specialized in Healthcare

Our team comprises of industry specialists and research experts from life sciences area holding degree in Medicine, Doctor of Pharmacy, M.Sc. in Pharmacy, Pharma MBAs, and Biotechnology.